137 related articles for article (PubMed ID: 12411444)
1. Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8+ T cell recognition.
Ogata K; Jaramillo A; Cohen W; Briand JP; Connan F; Choppin J; Muller S; Wodak SJ
J Biol Chem; 2003 Jan; 278(2):1281-90. PubMed ID: 12411444
[TBL] [Abstract][Full Text] [Related]
2. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
[TBL] [Abstract][Full Text] [Related]
3. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
4. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
[TBL] [Abstract][Full Text] [Related]
5. Strategic mutations in the class I major histocompatibility complex HLA-A2 independently affect both peptide binding and T cell receptor recognition.
Baxter TK; Gagnon SJ; Davis-Harrison RL; Beck JC; Binz AK; Turner RV; Biddison WE; Baker BM
J Biol Chem; 2004 Jul; 279(28):29175-84. PubMed ID: 15131131
[TBL] [Abstract][Full Text] [Related]
6. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
[TBL] [Abstract][Full Text] [Related]
7. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
8. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
Stone JD; Stern LJ
J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
[TBL] [Abstract][Full Text] [Related]
9. T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.
Buslepp J; Zhao R; Donnini D; Loftus D; Saad M; Appella E; Collins EJ
J Biol Chem; 2001 Dec; 276(50):47320-8. PubMed ID: 11584024
[TBL] [Abstract][Full Text] [Related]
10. On the calculation of binding free energies using continuum methods: application to MHC class I protein-peptide interactions.
Froloff N; Windemuth A; Honig B
Protein Sci; 1997 Jun; 6(6):1293-301. PubMed ID: 9194189
[TBL] [Abstract][Full Text] [Related]
11. Computing the structure of bound peptides. Application to antigen recognition by class I major histocompatibility complex receptors.
Rosenfeld R; Zheng Q; Vajda S; DeLisi C
J Mol Biol; 1993 Dec; 234(3):515-21. PubMed ID: 8254656
[TBL] [Abstract][Full Text] [Related]
12. Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.
Bouvier M; Wiley DC
Proc Natl Acad Sci U S A; 1996 May; 93(10):4583-8. PubMed ID: 8643447
[TBL] [Abstract][Full Text] [Related]
13. Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide.
Kuhns JJ; Batalia MA; Yan S; Collins EJ
J Biol Chem; 1999 Dec; 274(51):36422-7. PubMed ID: 10593938
[TBL] [Abstract][Full Text] [Related]
14. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
[TBL] [Abstract][Full Text] [Related]
15. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida T; Parker KC; Turner RV; McFarland HF; Coligan JE; Biddison WE
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10859-63. PubMed ID: 7526383
[TBL] [Abstract][Full Text] [Related]
16. HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
Barouch D; Friede T; Stevanović S; Tussey L; Smith K; Rowland-Jones S; Braud V; McMichael A; Rammensee HG
J Exp Med; 1995 Dec; 182(6):1847-56. PubMed ID: 7500030
[TBL] [Abstract][Full Text] [Related]
17. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
Wang Z; Turner R; Baker BM; Biddison WE
J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
[TBL] [Abstract][Full Text] [Related]
18. Peptide sequences binding to MHC class I proteins.
Smith MH; Lam KS; Hersh EM; Lebl M; Grimes WJ
Mol Immunol; 1994 Dec; 31(18):1431-7. PubMed ID: 7823969
[TBL] [Abstract][Full Text] [Related]
19. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.
Lim JS; Kim S; Lee HG; Lee KY; Kwon TJ; Kim K
Mol Immunol; 1996 Feb; 33(2):221-30. PubMed ID: 8649443
[TBL] [Abstract][Full Text] [Related]
20. Structural patterns in class 1 major histocompatibility complex-restricted nonamer peptide binding to T-cell receptors.
T RR; Smith JC
Proteins; 2022 Sep; 90(9):1645-1654. PubMed ID: 35403257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
